Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Avadel Pharmaceuticals (AVDL) Long-Term Debt Repayments: 2016-2018

Historic Long-Term Debt Repayments for Avadel Pharmaceuticals (AVDL) over the last 1 years, with Sep 2018 value amounting to $430,000.

  • Avadel Pharmaceuticals' Long-Term Debt Repayments was N/A to $430,000 in Q3 2018 from the same period last year, while for Sep 2018 it was $6.3 million, marking a year-over-year change of. This contributed to the annual value of $161,000 for FY2014, which is 109.09% up from last year.
  • Per Avadel Pharmaceuticals' latest filing, its Long-Term Debt Repayments stood at $430,000 for Q3 2018, which was up 16.53% from $369,000 recorded in Q2 2018.
  • Avadel Pharmaceuticals' Long-Term Debt Repayments' 5-year high stood at $5.4 million during Q1 2018, with a 5-year trough of -$61,000 in Q3 2016.
  • For the 2-year period, Avadel Pharmaceuticals' Long-Term Debt Repayments averaged around $1.2 million, with its median value being $369,000 (2018).